There have been significant movements in the stock holdings of Church & Dwight Co., Inc. (CHD) in the biotech market. Several asset management firms like Ascent Group LLC, Carderock Capital Management Inc., and Intech Investment Management LLC have adjusted their stocks. Some have bought more shares while others have sold off some of their holdings. Despite setbacks like reporting sales below analyst estimates in Q1 earnings, Church & Dwight still managed to perform well, surpassing expectations in Q2 2025 earnings. The company continued to please investors, reaching a milestone of 498 straight quarters of dividend payments. Several investors are satisfied with the prospects of the company. Nevertheless, the company acknowledges competition and macro issues affecting its prospects. A strategic review is underway, and their growth strategy will be highlighted in the upcoming Barclays Conference 2025.
Church Dwight CHD News Analytics from Tue, 28 Jan 2025 08:00:00 GMT to Sat, 13 Sep 2025 20:58:31 GMT - Rating 2 - Innovation 5 - Information 6 - Rumor -3
